Munich - Delayed Quote EUR
Biomed-Lublin Wytwornia Surowic i Szczepionek SA (6NQ.MU)
1.2240
-0.0680
(-5.26%)
At close: May 30 at 8:07:05 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
62,656
58,607
50,383
41,154
40,159
Cost of Revenue
24,510
23,440
22,450
18,487
19,592
Gross Profit
38,145
35,167
27,934
22,667
20,567
Operating Expense
29,317
26,354
18,678
16,111
14,101
Operating Income
8,828
8,813
9,256
6,556
6,466
Net Non Operating Interest Income Expense
-2,457
-1,211
-1,610
-1,270
-1,581
Pretax Income
6,064
6,569
8,346
5,893
4,314
Tax Provision
1,619
1,811
2,265
1,644
-126
Net Income Common Stockholders
4,446
4,758
6,081
4,249
4,439
Diluted NI Available to Com Stockholders
4,446
4,758
6,081
4,249
4,439
Basic EPS
0.07
0.07
0.09
0.07
0.07
Diluted EPS
0.07
0.07
0.09
0.07
0.07
Basic Average Shares
70,260.4100
70,260.4100
65,383.6980
63,124.5990
62,260.4100
Diluted Average Shares
70,260.4100
70,260.4100
65,383.6980
63,124.5990
62,260.4100
Total Operating Income as Reported
9,174
8,647
9,842
7,192
5,926
Total Expenses
53,827
49,794
41,128
34,598
33,693
Net Income from Continuing & Discontinued Operation
4,446
4,758
6,081
4,249
4,439
Normalized Income
4,318.4555
5,085.6000
5,652.4900
4,557.8800
4,891.7900
Interest Income
--
481
321
--
65
Interest Expense
2,475
1,692
1,608
1,283
1,646
Net Interest Income
-2,457
-1,211
-1,610
-1,270
-1,581
EBIT
8,539
8,261
9,954
7,176
5,960
EBITDA
15,844
14,891
16,174
13,720
11,786
Reconciled Cost of Revenue
24,510
23,440
22,450
18,487
19,592
Reconciled Depreciation
7,305
6,630
6,220
6,544
5,826
Net Income from Continuing Operation Net Minority Interest
4,446
4,758
6,081
4,249
4,439
Total Unusual Items Excluding Goodwill
174
-455
587
-429
-559
Total Unusual Items
174
-455
587
-429
-559
Normalized EBITDA
15,670
15,346
15,587
14,149
12,345
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0.0002
Tax Effect of Unusual Items
46.4555
-127.4000
158.4900
-120.1200
-106.2100
12/31/2020 - 3/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade